Anti-aging Drugs for Dogs Market: Industry Trends and Global Forecasts, Till 2040 - Distribution by Type of Molecule, Type of Biologic, Route of Administration, Type of Formulation, Type of Aging, Type of Canine Population, Geographical Regions and Sales
Description
ANTI-AGING DRUGS FOR DOGS MARKET
As per Roots Analysis, the anti-aging drugs for dogs market is estimated to grow from USD 91 million in the current year to USD 5,344 million by 2035, at a CAGR of 34% during the forecast period, till 2035.
Anti-aging Drugs for Dogs Market
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Molecule
Aging is a series of molecular and cellular alterations that take place in dogs as they grow older. These modifications progressively lead to a decline in physical and mental abilities, resulting in a heightened vulnerability to illnesses and death. The process of aging in dogs is shaped by a complex interaction of genetic, biological, and environmental factors. Significantly, larger dog breeds usually undergo age-related transformations more quickly than small dog breeds.
Over the years, the number of pet dogs has grown significantly. The American Veterinary Medical Association states that the number of dogs has grown continuously from 52.9 million in 1996 to 89.7 million in 2024. Further, the number of households with pets has risen from 31.3 million in 1996 to 59.8 million in 2024. This trend emphasizes the rising need for creative healthcare solutions, such as treatments designed to increase the health span or elevate quality of life in older dogs. This is fueled by the desire of pet owners to invest in enhanced healthcare to improve their dog’s overall health and well-being.
Moreover, it is essential to emphasize that the biology of aging in dogs remains a largely unstudied area for the development of safe and effective treatments. Nonetheless, the rise in pet owner expenditures, continual innovation, and investor financial backing are expected to propel the growth of the dog anti-aging therapeutics market in the future.
ANTI-AGING DRUGS FOR DOGS MARKET: KEY INSIGHTS
The report delves into the current state of the anti-aging drugs for dogs market and identifies potential growth opportunities within industry. Some key findings from the report include:
1. Close to 15 anti-aging therapies for dogs are currently being investigated across various stages of development; more than 75% of developers are based in North America.
2. Around 30% of the anti-aging therapeutics for dogs are in clinical stages of development; further, most (>85%) of the therapies are being evaluated as monotherapies.
3. Stakeholders are enhancing their existing capabilities and strengthening their competencies in order to develop innovative anti-aging therapeutics, which can improve the health span of dogs.
4. In recent years, the industry has witnessed a substantial rise in the number of partnerships to develop canine longevity drugs; more than 45% of the deals have been focused on the research and development initiatives.
5. Close to 30% of the funding rounds were instances of venture capital rounds received for the development of anti-aging therapeutics for dogs with an aim to improve health span in canines.
6. The growing scientific literature is indicative of the active involvement of stakeholders in research and development focused on understanding canine longevity; more than 20% of the articles were published in 2024.
7. 50% of the patents were filed / granted in WIPO jurisdiction; notably, Postrel Richard, having filed two patents, emerged as the leading assignee.
8. The global anti-aging therapeutics for dogs market is anticipated to grow at an annualized rate of 28% till 2040; further, the market in Asia-Pacific is likely to grow at a faster pace.
9. The tablets sub-segment is likely to capture majority of the overall market share, owing to the ease of administration and affordability as compared to other formulations.
10. With the growing population of aging dogs and increasing awareness among pet owners about managing age-related issues, the demand for effective solutions is expected to rise significantly.
ANTI AGING DRUGS FOR DOGS MARKET: KEY SEGMENTS
Small Molecules Hold the Largest Share of Anti-aging Drugs for Dogs Market
In terms of types of molecules, the market is segmented across biologics and small molecules. In the current year, the small molecules segment is likely to capture the entire market share. It is worth highlighting that the market for biologics segment is likely to grow at a high CAGR (38%), during the forecast period. This is attributed to multiple benefits of biology including precise treatment and improved outcomes, setting the stage for the expansion of this segment in the anticipated future.
Antisense Oligonucleotides Captures Majority of the Anti-aging Drugs for Dogs Market Share
In terms of types of biologics, the market is segmented across antisense oligonucleotides, gene therapies and other biologics. In the current year, antisense oligonucleotides sub-segment is likely to capture the complete share in the overall market. The biologics segment is likely to grow at a high CAGR (38%), during the forecast period. This is due to the various advantages of biologics such as targeted treatment and enhanced results, paving the way for the growth of this sector in the anticipated future.
Oral Route Holds the Largest Share in the Short Term
This segment highlights the distribution of global anti-aging dogs market across different routes of administration, such as oral, intravenous and other routes. In the short term, the oral route of administration segment is likely to capture the complete share in the overall market during the forecast period. This can be attributed to its convenience, ease of administration, and the likely preference among pet owners.
Injections Segment is Likely to Capture the Majority of the Market Share in the Future
This segment highlights the distribution of global market size across different types of formulations, such as injections, tablets and other formulations. By 2040, the injections segment is likely to capture maximum anti-aging drugs for canine’s market share (~75%). This is due to the increased bioavailability and quicker therapeutic effects provided by injections related to oral supplements or other methods, making them the favored choice for addressing aging in dogs.
Metabolic Aging Accounts for the Complete Market Share in the Current Year
This segment highlights the distribution of the global market across different types of ageing. Notably, in the current year, the metabolic aging segment is likely to capture the complete share in the overall market. This is because metabolic dysfunction primarily drives the canine aging process. Therefore, therapies targeting these metabolic pathways can effectively manage the aging process. It is worth highlighting that the market for metabolic aging is likely to grow at a CAGR of 26%, during the forecast period.
Majority of the Anti-aging Drugs for Dogs Market is Captured by Senior Dogs
This segment highlights the distribution of the global market value across different types of canine population targeted, such as senior dogs, large giant dogs and others. In the short term, the senior dogs segment is likely to capture the complete share in the overall market. This is because current drug development programs and clinical studies are focused on senior dogs, which represent the largest share of the dog population.
Asia-Pacific is Likely to Propel the Growth of the Anti-aging Therapeutics Market for Dogs
Our estimates suggest that North America is likely to capture the complete share in the overall market in the present year. This is due to the well-established veterinary infrastructure and the concentration of advanced clinical research initiatives in the region. Further, by 2026, the first drug, named LOY-002 is expected to attain approval in the US. It is worth highlighting that the market in Asia-Pacific is likely to attain higher anti-aging drugs for dogs market growth rate (CAGR) of 45%, during the period 2029-2040.
Primary Research Overview
Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes transcripts of the following other third-party discussions:
As per Roots Analysis, the anti-aging drugs for dogs market is estimated to grow from USD 91 million in the current year to USD 5,344 million by 2035, at a CAGR of 34% during the forecast period, till 2035.
Anti-aging Drugs for Dogs Market
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Molecule
- Biologics
- Small Molecules
- Antisense Oligonucleotides
- Cell Therapies
- Gene Therapies
- Oral
- Intravenous
- Other Routes
- Injections
- Tablets
- Other Formulations
- Metabolic Aging
- Cellular Aging
- Others
- Senior Dogs
- Large and Giant Dogs
- Others
- Rest of the World
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
- Latin America
Aging is a series of molecular and cellular alterations that take place in dogs as they grow older. These modifications progressively lead to a decline in physical and mental abilities, resulting in a heightened vulnerability to illnesses and death. The process of aging in dogs is shaped by a complex interaction of genetic, biological, and environmental factors. Significantly, larger dog breeds usually undergo age-related transformations more quickly than small dog breeds.
Over the years, the number of pet dogs has grown significantly. The American Veterinary Medical Association states that the number of dogs has grown continuously from 52.9 million in 1996 to 89.7 million in 2024. Further, the number of households with pets has risen from 31.3 million in 1996 to 59.8 million in 2024. This trend emphasizes the rising need for creative healthcare solutions, such as treatments designed to increase the health span or elevate quality of life in older dogs. This is fueled by the desire of pet owners to invest in enhanced healthcare to improve their dog’s overall health and well-being.
Moreover, it is essential to emphasize that the biology of aging in dogs remains a largely unstudied area for the development of safe and effective treatments. Nonetheless, the rise in pet owner expenditures, continual innovation, and investor financial backing are expected to propel the growth of the dog anti-aging therapeutics market in the future.
ANTI-AGING DRUGS FOR DOGS MARKET: KEY INSIGHTS
The report delves into the current state of the anti-aging drugs for dogs market and identifies potential growth opportunities within industry. Some key findings from the report include:
1. Close to 15 anti-aging therapies for dogs are currently being investigated across various stages of development; more than 75% of developers are based in North America.
2. Around 30% of the anti-aging therapeutics for dogs are in clinical stages of development; further, most (>85%) of the therapies are being evaluated as monotherapies.
3. Stakeholders are enhancing their existing capabilities and strengthening their competencies in order to develop innovative anti-aging therapeutics, which can improve the health span of dogs.
4. In recent years, the industry has witnessed a substantial rise in the number of partnerships to develop canine longevity drugs; more than 45% of the deals have been focused on the research and development initiatives.
5. Close to 30% of the funding rounds were instances of venture capital rounds received for the development of anti-aging therapeutics for dogs with an aim to improve health span in canines.
6. The growing scientific literature is indicative of the active involvement of stakeholders in research and development focused on understanding canine longevity; more than 20% of the articles were published in 2024.
7. 50% of the patents were filed / granted in WIPO jurisdiction; notably, Postrel Richard, having filed two patents, emerged as the leading assignee.
8. The global anti-aging therapeutics for dogs market is anticipated to grow at an annualized rate of 28% till 2040; further, the market in Asia-Pacific is likely to grow at a faster pace.
9. The tablets sub-segment is likely to capture majority of the overall market share, owing to the ease of administration and affordability as compared to other formulations.
10. With the growing population of aging dogs and increasing awareness among pet owners about managing age-related issues, the demand for effective solutions is expected to rise significantly.
ANTI AGING DRUGS FOR DOGS MARKET: KEY SEGMENTS
Small Molecules Hold the Largest Share of Anti-aging Drugs for Dogs Market
In terms of types of molecules, the market is segmented across biologics and small molecules. In the current year, the small molecules segment is likely to capture the entire market share. It is worth highlighting that the market for biologics segment is likely to grow at a high CAGR (38%), during the forecast period. This is attributed to multiple benefits of biology including precise treatment and improved outcomes, setting the stage for the expansion of this segment in the anticipated future.
Antisense Oligonucleotides Captures Majority of the Anti-aging Drugs for Dogs Market Share
In terms of types of biologics, the market is segmented across antisense oligonucleotides, gene therapies and other biologics. In the current year, antisense oligonucleotides sub-segment is likely to capture the complete share in the overall market. The biologics segment is likely to grow at a high CAGR (38%), during the forecast period. This is due to the various advantages of biologics such as targeted treatment and enhanced results, paving the way for the growth of this sector in the anticipated future.
Oral Route Holds the Largest Share in the Short Term
This segment highlights the distribution of global anti-aging dogs market across different routes of administration, such as oral, intravenous and other routes. In the short term, the oral route of administration segment is likely to capture the complete share in the overall market during the forecast period. This can be attributed to its convenience, ease of administration, and the likely preference among pet owners.
Injections Segment is Likely to Capture the Majority of the Market Share in the Future
This segment highlights the distribution of global market size across different types of formulations, such as injections, tablets and other formulations. By 2040, the injections segment is likely to capture maximum anti-aging drugs for canine’s market share (~75%). This is due to the increased bioavailability and quicker therapeutic effects provided by injections related to oral supplements or other methods, making them the favored choice for addressing aging in dogs.
Metabolic Aging Accounts for the Complete Market Share in the Current Year
This segment highlights the distribution of the global market across different types of ageing. Notably, in the current year, the metabolic aging segment is likely to capture the complete share in the overall market. This is because metabolic dysfunction primarily drives the canine aging process. Therefore, therapies targeting these metabolic pathways can effectively manage the aging process. It is worth highlighting that the market for metabolic aging is likely to grow at a CAGR of 26%, during the forecast period.
Majority of the Anti-aging Drugs for Dogs Market is Captured by Senior Dogs
This segment highlights the distribution of the global market value across different types of canine population targeted, such as senior dogs, large giant dogs and others. In the short term, the senior dogs segment is likely to capture the complete share in the overall market. This is because current drug development programs and clinical studies are focused on senior dogs, which represent the largest share of the dog population.
Asia-Pacific is Likely to Propel the Growth of the Anti-aging Therapeutics Market for Dogs
Our estimates suggest that North America is likely to capture the complete share in the overall market in the present year. This is due to the well-established veterinary infrastructure and the concentration of advanced clinical research initiatives in the region. Further, by 2026, the first drug, named LOY-002 is expected to attain approval in the US. It is worth highlighting that the market in Asia-Pacific is likely to attain higher anti-aging drugs for dogs market growth rate (CAGR) of 45%, during the period 2029-2040.
Primary Research Overview
Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes transcripts of the following other third-party discussions:
- Co-founder, Small Company in the US
- Chief Executive Officer, Mid-sized Company in the US
- Chair and Professor, Public Research University in the US
- Professor, Public Research University in the US
- Biologist and Biogerontologist, Public University in the US
- Alive
- Genflow Bioscience
- JangoPet
- Loyal
- Rejuvenate Bio
- Telomir Pharmaceuticals
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the anti-aging drugs for dogs market, focusing on key market segments, including [A] type of molecule, [B] type of biologic, [C] route of administration, [D] type of formulation, [E] type of aging [F] type of canine population [G] geographical regions.
- Market Landscape: provides a detailed assessment of the anti-aging therapeutics for dogs based on several relevant parameters, such as [A] stage of development, [B] type of molecule, [C] mechanism of action, [D] biological targets, [E] type of therapy, [F] route of administration, [G] type of formulation, [H] type of aging, and [I] target species, and [J] company overview.
- Company Competitiveness Analysis: A comprehensive competitive analysis of anti-aging drugs for dogs market, examining factors, such as [A] supplier strength [B] portfolio diversity and [C] portfolio diversity.
- Company Profiles: In-depth profiles of prominent players engaged in this domain, that are currently involved in anti-aging therapeutics for dogs market, focusing on [A] year of establishment, [B] location of headquarters, [C] anti-aging therapeutics for dogs portfolio, [D] recent developments and [E] an informed future outlook.
- Partnerships and Collaborations An insightful analysis of the partnerships and collaborations inked between stakeholders engaged in the anti-aging therapeutics for dogs market based on various relevant parameters, including [A] year of partnership, [B] type of partnership, [C] type of partner and [D] most active players.
- Funding and Investment Analysis: A comprehensive examination of various funding and investments raised by developers of anti-aging therapeutics for dogs, based on relevant parameters, including [A] such as year of funding, [B] amount invested [C] type of funding, [D] regional distribution, and [E] most active players.
- Publication Analysis: A detailed review of various peer-reviewed, scientific articles related to research on anti-aging therapeutics for dogs, based on relevant parameters, such as [A] year of publication, [B] type of publication, [C] popular publisher and [D]key journals.
- Patent Analysis: An in-depth analysis of various patents that have been filed / granted for anti-aging therapeutics for dogs, taking into consideration parameters, such as [A] publication year, [B] type of patent, [C] application year, [D] patent jurisdiction, [E] leading individual assignees.
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- What is the current global capacity of developers?
- What factors are likely to influence the evolution of this market?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
- Free Updated report if the report is 6-12 months old or older
Table of Contents
166 Pages
- 1. Report Overview
- 1.1. Context
- 1.2. Project Objectives
- 2. Research Methodology
- 2.1. Chapter Overview
- 2.2. Research Assumptions
- 2.2.1. Market Landscape And Market Trends
- 2.2.2. Market Forecast And Opportunity Analysis
- 2.2.3. Comparative Analysis
- 2.3. Database Building
- 2.3.1. Data Collection
- 2.3.2. Data Validation
- 2.3.3. Data Analysis
- 2.4. Project Methodology
- 2.4.1. Secondary Research
- 2.4.1.1. Annual Reports
- 2.4.1.2. Academic Research Papers
- 2.4.1.3. Company Websites
- 2.4.1.4. Investor Presentations
- 2.4.1.5. Regulatory Filings
- 2.4.1.6. White Papers
- 2.4.1.7. Industry Publications
- 2.4.1.8. Conferences And Seminars
- 2.4.1.9. Government Portals
- 2.4.1.10. Media And Press Releases
- 2.4.1.11. Newsletters
- 2.4.1.12. Industry Databases
- 2.4.1.13. Roots Proprietary Databases
- 2.4.1.14. Paid Databases And Sources
- 2.4.1.15. Social Media Portals
- 2.4.1.16. Other Secondary Sources
- 2.4.2. Primary Research
- 2.4.2.1. Types Of Primary Research
- 2.4.2.1.1. Qualitative Research
- 2.4.2.1.2. Quantitative Research
- 2.4.2.1.3. Hybrid Approach
- 2.4.2.2. Advantages Of Primary Research
- 2.4.2.3. Techniques For Primary Research
- 2.4.2.3.1. Interviews
- 2.4.2.3.2. Surveys
- 2.4.2.3.3. Focus Groups
- 2.4.2.3.4. Observational Research
- 2.4.2.3.5. Social Media Interactions
- 2.4.2.4. Key Opinion Leaders Considered In Primary Research
- 2.4.2.4.1. Company Executives (Cxos)
- 2.4.2.4.2. Board Of Directors
- 2.4.2.4.3. Company Presidents And Vice Presidents
- 2.4.2.4.4. Research And Development Heads
- 2.4.2.4.5. Technical Experts
- 2.4.2.4.6. Subject Matter Experts
- 2.4.2.4.7. Scientists
- 2.4.2.4.8. Doctors And Other Healthcare Providers
- 2.4.2.5. Ethics And Integrity
- 2.4.2.5.1. Research Ethics
- 2.4.2.5.2. Data Integrity
- 2.4.3. Analytical Tools And Databases
- 2.5. Robust Quality Control
- 3. Market Dynamics
- 3.1. Chapter Overview
- 3.2. Forecast Methodology
- 3.2.1. Top-down Approach
- 3.2.2. Bottom-up Approach
- 3.2.3. Hybrid Approach
- 3.3. Market Assessment Framework
- 3.3.1. Total Addressable Market (Tam)
- 3.3.2. Serviceable Addressable Market (Sam)
- 3.3.3. Serviceable Obtainable Market (Som)
- 3.3.4. Currently Acquired Market (Cam)
- 3.4. Forecasting Tools And Techniques
- 3.4.1. Qualitative Forecasting
- 3.4.2. Correlation
- 3.4.3. Regression
- 3.4.4. Extrapolation
- 3.4.5. Convergence
- 3.4.6. Sensitivity Analysis
- 3.4.7. Scenario Planning
- 3.4.8. Data Visualization
- 3.4.9. Time Series Analysis
- 3.4.10. Forecast Error Analysis
- 3.5. Key Considerations
- 3.5.1. Demographics
- 3.5.2. Government Regulations
- 3.5.3. Reimbursement Scenarios
- 3.5.4. Market Access
- 3.5.5. Supply Chain
- 3.5.6. Industry Consolidation
- 3.5.7. Pandemic / Unforeseen Disruptions Impact
- 3.6. Limitations
- 4. Macro-economic Indicators
- 4.1. Chapter Overview
- 4.2. Market Dynamics
- 4.2.1. Time Period
- 4.2.1.1. Historical Trends
- 4.2.1.2. Current And Forecasted Estimates
- 4.2.2. Currency Coverage
- 4.2.2.1. Major Currencies Affecting The Market
- 4.2.2.2. Factors Affecting Currency Fluctuations
- 4.2.2.3. Impact Of Currency Fluctuations On The Industry
- 4.2.3. Foreign Currency Exchange Rate
- 4.2.3.1. Impact Of Foreign Exchange Rate Volatility On The Market
- 4.2.3.2. Strategies For Mitigating Foreign Exchange Risk
- 4.2.4. Recession
- 4.2.4.1. Assessment Of Current Economic Conditions And Potential Impact On The Market
- 4.2.4.2. Historical Analysis Of Past Recessions And Lessons Learnt
- 4.2.5. Inflation
- 4.2.5.1. Measurement And Analysis Of Inflationary Pressures In The Economy
- 4.2.5.2. Potential Impact Of Inflation On The Market Evolution
- 4.2.6. Interest Rates
- 4.2.6.1. Interest Rates And Their Impact On The Market
- 4.2.6.2. Strategies For Managing Interest Rate Risk
- 4.2.7. Commodity Flow Analysis
- 4.2.7.1. Type Of Commodity
- 4.2.7.2. Origins And Destinations
- 4.2.7.3. Value And Weights
- 4.2.7.4. Modes Of Transportation
- 4.2.8. Global Trade Dynamics
- 4.2.8.1. Import Scenario
- 4.2.8.2. Export Scenario
- 4.2.8.3. Trade Policies
- 4.2.8.4. Strategies For Mitigating The Risks Associated With Trade Barriers
- 4.2.8.5. Impact Of Trade Barriers On The Market
- 4.2.9. War Impact Analysis
- 4.2.9.1. Russian-ukraine War
- 4.2.9.2. Israel-hamas War
- 4.2.10. Covid Impact / Related Factors
- 4.2.10.1. Global Economic Impact
- 4.2.10.2. Industry-specific Impact
- 4.2.10.3. Government Response And Stimulus Measures
- 4.2.10.4. Future Outlook And Adaptation Strategies
- 4.2.11. Other Indicators
- 4.2.11.1. Fiscal Policy
- 4.2.11.2. Consumer Spending
- 4.2.11.3. Gross Domestic Product (Gdp)
- 4.2.11.4. Employment
- 4.2.11.5. Taxes
- 4.2.11.6. Stock Market Performance
- 4.2.11.7. Cross-border Dynamics
- 4.3. Concluding Remarks
- 5. Executive Summary
- 6. Introduction
- 6.1. An Overview Of Aging In Dogs
- 6.2. Key Factors Affecting Aging In Dogs
- 6.3. Symptoms Of Aging In Dogs
- 6.4. Dog Aging Project
- 6.5. Advancements In Anti-aging Therapeutics For Dogs
- 6.6. Future Perspective
- 7. Market Landscape: Anti-aging Therapeutics For Dogs
- 7.1. Methodology And Key Parameters
- 7.2. Anti-aging Therapeutics For Dogs: Overall Market Landscape
- 7.2.1. Analysis By Stage Of Development
- 7.2.2. Analysis By Type Of Molecule
- 7.2.3. Analysis By Mechanism Of Action
- 7.2.4. Analysis By Biological Target
- 7.2.5. Analysis By Type Of Therapy
- 7.2.6. Analysis By Dosing Frequency
- 7.2.7. Analysis By Route Of Administration
- 7.2.8. Analysis By Type Of Formulation
- 7.2.9. Analysis By Type Of Aging
- 7.2.10. Analysis By Target Species
- 7.3. Developers Of Anti-aging Therapeutics For Dogs
- 7.3.1. Analysis By Year Of Establishment
- 7.3.2. Analysis By Company Size
- 7.3.3. Analysis By Location Of Headquarters
- 7.3.4. Analysis By Type Of Developer
- 8. Company Competitiveness Analysis
- 8.1. Methodology And Key Parameters
- 8.2. Scoring Criteria
- 8.3. Anti-aging Therapeutic Developers For Dogs: Company Competitiveness Analysis
- 8.4. Key Players
- 9. Company Profiles
- 9.1. Loyal
- 9.1.1. Company Overview
- 9.1.2. Anti-aging Therapeutics For Dogs Pipeline
- 9.1.3. Recent Initiatives And Future Outlook
- 9.2. Alive
- 9.3. Genflow Bioscience
- 9.4. Jangopet
- 9.5. Rejuvenate Bio
- 9.6. Telomir Pharmaceuticals
- 10. Partnerships And Collaborations
- 10.1. Partnership Models
- 10.2. Parameters
- 10.3. Anti-aging Therapeutics For Dogs: Partnerships And Collaborations
- 10.3.1. Analysis By Year Of Partnership
- 10.3.2. Analysis By Type Of Partnership
- 10.3.3. Analysis By Year And Type Of Partnership
- 10.3.4. Analysis By Type Of Partner
- 10.3.5. Most Active Players: Analysis By Number Of Partnerships
- 10.3.6. Analysis By Geography
- 10.3.6.1. Distribution By Country
- 10.3.6.2. Distribution By Region
- 11. Funding And Investments
- 11.1. Funding Models
- 11.2. Funding Lifecycle Analysis
- 11.3. Investment Case: Risk And Return
- 11.4. Anti-aging Therapeutics For Dogs: Funding And Investments
- 11.4.1. Analysis Of Instances By Year Of Funding
- 11.4.2. Analysis Of Instances By Type Of Funding
- 11.4.3. Analysis Of Instances By Year And Type Of Funding
- 11.4.4. Analysis Of Amount By Year Of Funding
- 11.4.5. Analysis Of Amount By Type Of Funding
- 11.4.6. Analysis By Geography
- 11.4.7. Most Active Players: Analysis By Number Of Funding Instances
- 11.4.8. Most Active Players: Analysis By Amount Invested
- 11.4.9. Most Active Investors: Analysis By Number Of Funding Instances
- 11.5. Summary
- 11.6. Key Takeaways
- 12. Publication Analysis
- 12.1. Methodology
- 12.2. Parameters
- 12.3. Anti-aging Therapeutics For Dogs: Publications
- 12.3.1. Analysis By Year Of Publication
- 12.3.2. Analysis By Type Of Publication
- 12.3.3. Most Active Publisher: Analysis By Number Of Publications
- 12.3.4. Key Journal: Analysis By Number Of Publications
- 12.3.5. Key Journal: Analysis By Impact Factor
- 13. Patent Analysis
- 13.1. Methodology
- 13.2. Parameters
- 13.3. Anti-aging Therapeutics For Dogs: Patent Analysis
- 13.3.1. Analysis By Publication Year
- 13.3.2. Analysis By Type Of Patent
- 13.3.3. Analysis By Type Of Patent And Publication Year
- 13.3.4. Analysis By Application Year
- 13.3.5. Analysis By Patent Jurisdiction
- 13.3.6. Leading Individual Assignees: Analysis By Number Of Patents
- 13.3.7. Analysis By Cpc Symbols
- 13.3.8. Definition Of Top Cpc Symbols
- 14. Global Anti-aging Therapeutics For Dogs Market
- 14.1. Forecast Model
- 14.2. Key Assumptions
- 14.3. Forecast Methodology
- 14.4. Global Anti-aging Therapeutics For Dogs Market, Till 2040
- 14.4.1. Multivariate Scenario Analysis
- 14.4.1.1. Conservative Scenario
- 14.4.1.2. Optimistic Scenario
- 14.5. Key Market Segmentations
- 15. Anti-aging Therapeutics For Dogs Market, By Type Of Molecule
- 15.1. Anti-aging Therapeutics For Dogs Market: Distribution By Type Of Molecule
- 15.1.1. Anti-aging Therapeutics For Dogs Market For Biologics, Forecasted Estimates (Till 2040)
- 15.1.2. Anti-aging Therapeutics For Dogs Market For Small Molecules, Forecasted Estimates (Till 2040)
- 15.2. Data Triangulation And Validation
- 16. Anti-aging Therapeutics For Dogs Market, By Type Of Biologic
- 16.1. Anti-aging Therapeutics For Dogs Market: Distribution By Type Of Biologic
- 16.1.1. Anti-aging Therapeutics For Dogs Market For Antisense Oligonucleotides, Forecasted Estimates (Till 2040)
- 16.1.2. Anti-aging Therapeutics For Dogs Market For Cell Therapies, Forecasted Estimates (Till 2040)
- 16.1.3. Anti-aging Therapeutics For Dogs Market For Gene Therapies, Forecasted Estimates (Till 2040)
- 16.2. Data Triangulation And Validation
- 17. Anti-aging Therapeutics For Dogs Market, By Route Of Administration
- 17.1. Anti-aging Therapeutics For Dogs Market: Distribution By Route Of Administration
- 17.1.1. Anti-aging Therapeutics For Dogs Market For Oral, Forecasted Estimates (Till 2040)
- 17.1.2. Anti-aging Therapeutics For Dogs Market For Intravenous, Forecasted Estimates (Till 2040)
- 17.1.3. Anti-aging Therapeutics For Dogs Market For Other Routes, Forecasted Estimates (Till 2040)
- 17.2. Data Triangulation And Validation
- 18. Anti-aging Therapeutics For Dogs Market, By Type Of Formulation
- 18.1. Anti-aging Therapeutics For Dogs Market: Distribution By Type Of Formulation
- 18.1.1. Anti-aging Therapeutics For Dogs Market For Tablets, Forecasted Estimates (Till 2040)
- 18.1.2. Anti-aging Therapeutics For Dogs Market For Injections, Forecasted Estimates (Till 2040)
- 18.1.3. Anti-aging Therapeutics For Dogs Market For Other Formulations, Forecasted Estimates (Till 2040)
- 18.2. Data Triangulation And Validation
- 19. Anti-aging Therapeutics For Dogs Market, By Type Of Aging
- 19.1. Anti-aging Therapeutics For Dogs Market: Distribution By Type Of Aging
- 19.1.1. Anti-aging Therapeutics For Dogs Market For Metabolic Aging, Forecasted Estimates (Till 2040)
- 19.1.2. Anti-aging Therapeutics For Dogs Market For Cellular Aging, Forecasted Estimates (Till 2040)
- 19.1.3. Anti-aging Therapeutics For Dogs Market For Others, Forecasted Estimates (Till 2040)
- 19.2. Data Triangulation And Validation
- 20. Anti-aging Therapeutics For Dogs Market, By Type Of Canine Population Targeted
- 20.1. Anti-aging Therapeutics For Dogs Market: Distribution By Type Of Canine Population Targeted
- 20.1.1. Anti-aging Therapeutics For Dogs Market For Senior Dogs, Forecasted Estimates (Till 2040)
- 20.1.2. Anti-aging Therapeutics For Dogs Market For Large And Giant Dogs, Forecasted Estimates (Till 2040)
- 20.1.3. Anti-aging Therapeutics For Dogs Market For Others, Forecasted Estimates (Till 2040)
- 20.2. Data Triangulation And Validation
- 21. Anti-aging Therapeutics For Dogs Market, By Geographical Regions
- 21.1. Anti-aging Therapeutics For Dogs Market: Distribution By Geographical Regions
- 21.1.1. Anti-aging Therapeutics For Dogs Market In North America, Forecasted Estimates (Till 2040)
- 21.1.2. Anti-aging Therapeutics For Dogs Market In Europe, Forecasted Estimates (Till 2040)
- 21.1.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific, Forecasted Estimates (Till 2040)
- 21.1.4. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa, Forecasted Estimates (Till 2040)
- 21.1.5. Anti-aging Therapeutics For Dogs Market In Latin America, Forecasted Estimates (Till 2040)
- 21.2. Data Triangulation And Validation
- 22. Market Forecast Opportunity Analysis: North America
- 22.1. Anti-aging Therapeutics For Dogs Market In North America: Distribution By Type Of Molecule
- 22.1.1. Anti-aging Therapeutics For Dogs Market In North America For Small Molecules, Forecasted Estimates (Till 2040)
- 22.1.2. Anti-aging Therapeutics For Dogs Market In North America For Biologics, Forecasted Estimates (Till 2040)
- 22.2. Anti-aging Therapeutics For Dogs Market In North America: Distribution By Type Of Biologic
- 22.2.1. Anti-aging Therapeutics For Dogs Market In North America For Antisense Oligonucleotides, Forecasted Estimates (Till 2040)
- 22.2.2. Anti-aging Therapeutics For Dogs Market In North America For Cell Therapies, Forecasted Estimates (Till 2040)
- 22.2.3. Anti-aging Therapeutics For Dogs Market In North America For Gene Therapies, Forecasted Estimates (Till 2040)
- 22.3. Anti-aging Therapeutics For Dogs Market In North America: Distribution By Route Of Administration
- 22.3.1. Anti-aging Therapeutics For Dogs Market In North America For Oral, Forecasted Estimates (Till 2040)
- 22.3.2. Anti-aging Therapeutics For Dogs Market In North America For Intravenous, Forecasted Estimates (Till 2040)
- 22.3.3. Anti-aging Therapeutics For Dogs Market In North America For Other Routes, Forecasted Estimates (Till 2040)
- 22.4. Anti-aging Therapeutics For Dogs Market In North America: Distribution By Type Of Formulation
- 22.4.1. Anti-aging Therapeutics For Dogs Market In North America For Injections, Forecasted Estimates (Till 2040)
- 22.4.2. Anti-aging Therapeutics For Dogs Market In North America For Tablets, Forecasted Estimates (Till 2040)
- 22.4.3. Anti-aging Therapeutics For Dogs Market In North America For Other Formulations, Forecasted Estimates (Till 2040)
- 22.5. Anti-aging Therapeutics For Dogs Market In North America: Distribution By Type Of Aging
- 22.5.1. Anti-aging Therapeutics For Dogs Market In North America For Metabolic Aging, Forecasted Estimates (Till 2040)
- 22.5.2. Anti-aging Therapeutics For Dogs Market In North America For Cellular Aging, Forecasted Estimates (Till 2040)
- 22.5.3. Anti-aging Therapeutics For Dogs Market In North America For Others, Forecasted Estimates (Till 2040)
- 22.6. Anti-aging Therapeutics For Dogs Market In North America: Distribution By Type Of Canine Population Targeted
- 22.6.1. Anti-aging Therapeutics For Dogs Market In North America For Senior Dogs, Forecasted Estimates (Till 2040)
- 22.6.2. Anti-aging Therapeutics For Dogs Market In North America For Large And Giant Dogs, Forecasted Estimates (Till 2040)
- 22.6.3. Anti-aging Therapeutics For Dogs Market In North America For Others, Forecasted Estimates (Till 2040)
- 23. Market Forecast Opportunity Analysis: Europe
- 23.1. Anti-aging Therapeutics For Dogs Market In Europe: Distribution By Type Of Molecule
- 23.1.1. Anti-aging Therapeutics For Dogs Market In Europe For Small Molecules, Forecasted Estimates (Till 2040)
- 23.1.2. Anti-aging Therapeutics For Dogs Market In Europe For Biologics, Forecasted Estimates (Till 2040)
- 23.2. Anti-aging Therapeutics For Dogs Market In Europe: Distribution By Type Of Biologic
- 23.2.1. Anti-aging Therapeutics For Dogs Market In Europe For Antisense Oligonucleotides, Forecasted Estimates (Till 2040)
- 23.2.2. Anti-aging Therapeutics For Dogs Market In Europe For Cell Therapies, Forecasted Estimates (Till 2040)
- 23.2.3. Anti-aging Therapeutics For Dogs Market In Europe For Gene Therapies, Forecasted Estimates (Till 2040)
- 23.3. Anti-aging Therapeutics For Dogs Market In Europe: Distribution By Route Of Administration
- 23.3.1. Anti-aging Therapeutics For Dogs Market In Europe For Oral, Forecasted Estimates (Till 2040)
- 23.3.2. Anti-aging Therapeutics For Dogs Market In Europe For Intravenous, Forecasted Estimates (Till 2040)
- 23.3.3. Anti-aging Therapeutics For Dogs Market In Europe For Other Routes, Forecasted Estimates (Till 2040)
- 23.4. Anti-aging Therapeutics For Dogs Market In Europe: Distribution By Type Of Formulation
- 23.4.1. Anti-aging Therapeutics For Dogs Market In Europe For Injections, Forecasted Estimates (Till 2040)
- 23.4.2. Anti-aging Therapeutics For Dogs Market In Europe For Tablets, Forecasted Estimates (Till 2040)
- 23.4.3. Anti-aging Therapeutics For Dogs Market In Europe For Other Formulations, Forecasted Estimates (Till 2040)
- 23.5. Anti-aging Therapeutics For Dogs Market In Europe: Distribution By Type Of Aging
- 23.5.1. Anti-aging Therapeutics For Dogs Market In Europe For Metabolic Aging, Forecasted Estimates (Till 2040)
- 23.5.2. Anti-aging Therapeutics For Dogs Market In Europe For Cellular Aging, Forecasted Estimates (Till 2040)
- 23.5.3. Anti-aging Therapeutics For Dogs Market In Europe For Others, Forecasted Estimates (Till 2040)
- 23.6. Anti-aging Therapeutics For Dogs Market In Europe: Distribution By Type Of Canine Population Targeted
- 23.6.1. Anti-aging Therapeutics For Dogs Market In Europe For Senior Dogs, Forecasted Estimates (Till 2040)
- 23.6.2. Anti-aging Therapeutics For Dogs Market In Europe For Large And Giant Dogs, Forecasted Estimates (Till 2040)
- 23.6.3. Anti-aging Therapeutics For Dogs Market In Europe For Others, Forecasted Estimates (Till 2040)
- 24. Market Forecast Opportunity Analysis: Asia-pacific
- 24.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific: Distribution By Type Of Molecule
- 24.1.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Small Molecules, Forecasted Estimates (Till 2040)
- 24.1.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Biologics, Forecasted Estimates (Till 2040)
- 24.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific: Distribution By Type Of Biologic
- 24.2.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Antisense Oligonucleotides, Forecasted Estimates (Till 2040)
- 24.2.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Cell Therapies, Forecasted Estimates (Till 2040)
- 24.2.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Gene Therapies, Forecasted Estimates (Till 2040)
- 24.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific: Distribution By Route Of Administration
- 24.3.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Oral, Forecasted Estimates (Till 2040)
- 24.3.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Intravenous, Forecasted Estimates (Till 2040)
- 24.3.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Other Routes, Forecasted Estimates (Till 2040)
- 24.4. Anti-aging Therapeutics For Dogs Market In Asia-pacific: Distribution By Type Of Formulation
- 24.4.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Injections, Forecasted Estimates (Till 2040)
- 24.4.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Tablets, Forecasted Estimates (Till 2040)
- 24.4.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Other Formulations, Forecasted Estimates (Till 2040)
- 24.5. Anti-aging Therapeutics For Dogs Market In Asia-pacific: Distribution By Type Of Aging
- 24.5.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Metabolic Aging, Forecasted Estimates (Till 2040)
- 24.5.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Cellular Aging, Forecasted Estimates (Till 2040)
- 24.5.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Others, Forecasted Estimates (Till 2040)
- 24.6. Anti-aging Therapeutics For Dogs Market In Asia-pacific: Distribution By Type Of Canine Population Targeted
- 24.6.1. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Senior Dogs, Forecasted Estimates (Till 2040)
- 24.6.2. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Large And Giant Dogs, Forecasted Estimates (Till 2040)
- 24.6.3. Anti-aging Therapeutics For Dogs Market In Asia-pacific For Others, Forecasted Estimates (Till 2040)
- 25. Market Forecast Opportunity Analysis: Middle East And North Africa
- 25.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa: Distribution By Type Of Molecule
- 25.1.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Small Molecules, Forecasted Estimates (Till 2040)
- 25.1.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Biologics, Forecasted Estimates (Till 2040)
- 25.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa: Distribution By Type Of Biologic
- 25.2.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Antisense Oligonucleotides, Forecasted Estimates (Till 2040)
- 25.2.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Cell Therapies, Forecasted Estimates (Till 2040)
- 25.2.3. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Gene Therapies, Forecasted Estimates (Till 2040)
- 25.3. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa: Distribution By Route Of Administration
- 25.3.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Oral, Forecasted Estimates (Till 2040)
- 25.3.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Intravenous, Forecasted Estimates (Till 2040)
- 25.3.3. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Other Routes, Forecasted Estimates (Till 2040)
- 25.4. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa: Distribution By Type Of Formulation
- 25.4.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Injections, Forecasted Estimates (Till 2040)
- 25.4.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Tablets, Forecasted Estimates (Till 2040)
- 25.4.3. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Other Formulations, Forecasted Estimates (Till 2040)
- 25.5. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa: Distribution By Type Of Aging
- 25.5.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Metabolic Aging, Forecasted Estimates (Till 2040)
- 25.5.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Cellular Aging, Forecasted Estimates (Till 2040)
- 25.5.3. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Others, Forecasted Estimates (Till 2040)
- 25.6. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa: Distribution By Type Of Canine Population Targeted
- 25.6.1. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Senior Dogs, Forecasted Estimates (Till 2040)
- 25.6.2. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Large And Giant Dogs, Forecasted Estimates (Till 2040)
- 25.6.3. Anti-aging Therapeutics For Dogs Market In Middle East And North Africa For Others, Forecasted Estimates (Till 2040)
- 26. Market Forecast Opportunity Analysis: Latin America
- 26.1. Anti-aging Therapeutics For Dogs Market In Latin America: Distribution By Type Of Molecule
- 26.1.1. Anti-aging Therapeutics For Dogs Market In Latin America For Small Molecules, Forecasted Estimates (Till 2040)
- 26.1.2. Anti-aging Therapeutics For Dogs Market In Latin America For Biologics, Forecasted Estimates (Till 2040)
- 26.2. Anti-aging Therapeutics For Dogs Market In Latin America: Distribution By Type Of Biologic
- 26.2.1. Anti-aging Therapeutics For Dogs Market In Latin America For Antisense Oligonucleotides, Forecasted Estimates (Till 2040)
- 26.2.2. Anti-aging Therapeutics For Dogs Market In Latin America For Cell Therapies, Forecasted Estimates (Till 2040)
- 26.2.3. Anti-aging Therapeutics For Dogs Market In Latin America For Gene Therapies, Forecasted Estimates (Till 2040)
- 26.3. Anti-aging Therapeutics For Dogs Market In Latin America: Distribution By Route Of Administration
- 26.3.1. Anti-aging Therapeutics For Dogs Market In Latin America For Oral, Forecasted Estimates (Till 2040)
- 26.3.2. Anti-aging Therapeutics For Dogs Market In Latin America For Intravenous, Forecasted Estimates (Till 2040)
- 26.3.3. Anti-aging Therapeutics For Dogs Market In Latin America For Other Routes, Forecasted Estimates (Till 2040)
- 26.4. Anti-aging Therapeutics For Dogs Market In Latin America: Distribution By Type Of Formulation
- 26.4.1. Anti-aging Therapeutics For Dogs Market In Latin America For Injections, Forecasted Estimates (Till 2040)
- 26.4.2. Anti-aging Therapeutics For Dogs Market In Latin America For Tablets, Forecasted Estimates (Till 2040)
- 26.4.3. Anti-aging Therapeutics For Dogs Market In Latin America For Other Formulations, Forecasted Estimates (Till 2040)
- 26.5. Anti-aging Therapeutics For Dogs Market In Latin America: Distribution By Type Of Aging
- 26.5.1. Anti-aging Therapeutics For Dogs Market In Latin America For Metabolic Aging, Forecasted Estimates (Till 2040)
- 26.5.2. Anti-aging Therapeutics For Dogs Market In Latin America For Cellular Aging, Forecasted Estimates (Till 2040)
- 26.5.3. Anti-aging Therapeutics For Dogs Market In Latin America For Others, Forecasted Estimates (Till 2040)
- 26.6. Anti-aging Therapeutics For Dogs Market In Latin America: Distribution By Type Of Canine Population Targeted
- 26.6.1. Anti-aging Therapeutics For Dogs Market In Latin America For Senior Dogs, Forecasted Estimates (Till 2040)
- 26.6.2. Anti-aging Therapeutics For Dogs Market In Latin America For Large And Giant Dogs, Forecasted Estimates (Till 2040)
- 26.6.3. Anti-aging Therapeutics For Dogs Market In Latin America For Others, Forecasted Estimates (Till 2040)
- 27. Sales Forecast
- 27.1. Anti-aging Therapeutics For Dogs Market: Sales Forecast
- 27.1.1. Loy-002: Sales Forecast
- 27.1.2. Loy-003: Sales Forecast
- 27.1.3. Loy-001: Sales Forecast
- 27.1.4. Gf-1004: Sales Forecast
- 27.1.5. Telomir-1: Sales Forecast
- 27.1.6. Alive Gene Therapy: Sales Forecast
- 27.1.7. Rjb-01: Sales Forecast
- 27.1.8. Rjb-02: Sales Forecast
- 27.1.9. Unnamed (Rejuvenate Bio): Sales Forecast
- 27.1.10. Jango-relieve: Sales Forecast
- 27.1.11. Jango-renew: Sales Forecast
- 27.1.12. Jango-org-c1: Sales Forecast
- 28. Porter’s Five Forces Analysis
- 28.1. Chapter Overview
- 28.2. Methodology
- 28.3. Key Parameters
- 28.3.1. Threats Of New Entrants
- 28.3.2. Bargaining Power Of Buyers
- 28.3.3. Bargaining Power Of Developers
- 28.3.4. Threat Of Substitute Products
- 28.3.5. Rivalry Among Existing Competitors
- 28.4. Conclusion
- 29. Concluding Remarks
- 30. Appendix 1: Tabulated Data
- 31. Appendix 2: List Of Companies And Organizations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.